VICTORIA – ViVitro Labs, a Victoria-based cardiovascular device testing company, announced the acquisition of ProtomedLabs SASU, a medical device testing laboratory based in Marseille France.
The agreement will see the companies merge operations and form a single company operating under the name Vivitro Labs Inc. The new organization will extend ViVitro’s presence in Europe and will double the company’s contract testing and customization capabilities. Karim Mouneimne, General Manager of ProtomedLabs, will become President of the combined organization and move to ViVitro headquarters in Victoria, Canada.
“This acquisition and merger reflects our commitment to growing ViVitro’s resources, products and services to address evolving cardiovascular testing system needs for leading edge researchers and organizations,” said Scott Phillips, Owner and CEO of the StarFish Group and CEO of ViVitro Labs.
“ProtomedLabs has been the ViVitro sales agent for Europe, Israel, and Africa since 2015. We are excited to bring this successful partnership to the next level,” said Frederic Mouret, President & CEO, Protomed SA and owner of ProtomedLabs.
ViVitro Labs Inc., Canada, provides industry-leading cardiovascular test equipment and related laboratory testing and consulting services. The companies products are manufactured by StarFish Medical in Victoria.
